Johnson & Johnson COVID-19 vaccine generates immune response in trial – New York Post

Johnson & Johnson’s coronavirus vaccine generated a lasting immune response to the deadly bug in an early-stage clinical trial, the pharmaceutical giant said.
More than 90 percent of the study’s… [read more]